Show simple item record

dc.contributor.authorAgustí, Àlvar
dc.contributor.authorHedner, J.
dc.contributor.authorMarin, J.M.
dc.contributor.authorBarbé Illa, Ferran
dc.contributor.authorCazzola, M.
dc.contributor.authorRennard, S.
dc.date.accessioned2016-03-30T08:23:44Z
dc.date.issued2011
dc.identifier.issn0905-9180
dc.identifier.urihttp://hdl.handle.net/10459.1/56768
dc.description.abstractSleep quality is often poor in patients with chronic obstructive pulmonary disease (COPD), but these night-time symptoms are frequently unnoticed by physicians and/or not reported by patients themselves. Therefore, the prevalence and clinical impact of sleep disturbances and night-time symptoms in COPD is not well understood and has not been a clinical focus to date. To address this gap, an expert panel meeting was convened in Barcelona, Spain, in March 2011 to discuss the aetiology, evolution, burden, long-term clinical consequences and optimal management of night-time symptoms in COPD. The term ‘‘night-time symptoms’’ in COPD has not been distinctly defined in an objective sense but epidemiological data suggests that the prevalence of nocturnal symptoms and symptomatic sleep disturbance may exceed 75% in patients with COPD. The panel concluded that night-time symptoms in COPD are prevalent and bothersome; that their cause(s) are multiple and include demographic factors, such as age and obesity, pharmacotherapy, disease-specific symptoms and the presence of comorbid sleep disorders, and other medical conditions; and that potential long-term consequences can include lung function changes, increased exacerbation frequency, emergence or worsening of cardiovascular disease, cognitive effects, depression, impaired quality of life and increased mortality. To date, few interventional studies have investigated them, but emerging data suggest that bronchodilator therapy can improve them if deployed appropriately. In summary, night-time symptoms in COPD warrant further clinical investigation with validated tools.ca_ES
dc.language.isoengca_ES
dc.publisherEuropean Respiratory Societyca_ES
dc.relation.isformatofReproducció del document publicat a https://doi.org/10.1183/09059180.00004311ca_ES
dc.relation.ispartofEuropean Respiratory Review, 2011, vol. 20, núm. 1, p. 183-194ca_ES
dc.rights(c) ERS, 2011ca_ES
dc.subjectBurdenca_ES
dc.subjectchronic bronchitisca_ES
dc.subjectemphysemaca_ES
dc.subjectpharmacotherapyca_ES
dc.titleNight-time symptoms: a forgotten dimension of COPDca_ES
dc.typearticleca_ES
dc.identifier.idgrec019370
dc.type.versionpublishedVersionca_ES
dc.rights.accessRightsinfo:eu-repo/semantics/restrictedAccessca_ES
dc.identifier.doihttps://doi.org/10.1183/09059180.00004311
dc.date.embargoEndDate2025-01-01


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record